The pharma company expects that the next few quarters to continue to be soft due to the impact of global destocking in specialty chemicals and FY23 base effect
The pharma company expects that the next few quarters to continue to be soft due to the impact of global destocking in specialty chemicals and FY23 base effect The pharma company expects that the next few quarters to continue to be soft due to the impact of global destocking in specialty chemicals and FY23 base effect Moneycontrol Latest News Read More
हिन्दी 
English